Biofrontera Inc. (BFRI) Misses Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazil’s Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Oil settles lower on peace hopes, Saudi attacks limit losses
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
Biofrontera (BFRI) PT Lowered to $16 at Roth/MKM
August 15, 2024 1:44 PM EDTRoth/MKM analyst Jonathan Aschoff lowered the price target on Biofrontera (NASDAQ: BFRI) to $16.00 (from $25.00) while maintaining a Buy rating.
The analyst comments "BFRI ended 2Q24 with cash of $4.4M, enough to fund operations into early 2025. 2Q24 sales were $7.8M and we still... More



